文献速递传染病防控与疫情报告免疫规划

加拿大温哥华使用药物的青年及年轻成年人的COVID-19疫苗接种情况

COVID-19 vaccination among young people who use drugs in Vancouver, Canada.
PubMed 文献 · Vaccine · 2024-01-14

研究基于温哥华街头涉入的使用药物青年及年轻成年人前瞻性队列,分析2021年6月至11月SARS-CoV-2疫苗 uptake 相关因素。301名参与者中50.2%自报至少接种一剂;近期成瘾治疗参与和处方更安全供应与接种显著正相关,至少每周使用快克可卡因与接种显著负相关。疫苗犹豫最常见原因为对长期副作用的担忧(27.4%)。

要点

  • 301名使用药物青年及年轻成年人中,50.2%自报至少接种一剂SARS-CoV-2疫苗。
  • 近期参与成瘾治疗(AOR=2.46,95%CI:1.47-4.14)和获得处方更安全供应(AOR=2.33,95%CI:1.03-5.62)与接种显著正相关。
  • 至少每周使用快克可卡因者接种可能性显著更低(AOR=0.35,95%CI:0.12-0.92)。

核心结论

  • 使用药物青年及年轻成年人的疫苗 uptake 显著低于温哥华使用药物成年人及不列颠哥伦比亚省一般人群,同期分别为75%和93%至少接种一剂。
  • 研究结果提示将使用药物青年及年轻成年人连接至医疗保健和创新减害干预可能增加疫苗 uptake。
  • 对疫苗犹豫问题的回答揭示了与一般人群疫苗犹豫来源一致的复杂疫苗观点。
  • 针对错误信息的更广泛策略和促进循证疫苗信息可量身定制以应对使用药物青年及年轻成年人经历的独特需求和障碍。

研究设计与样本

  • 数据来源于At-Risk Youth Study,一项在加拿大温哥华街头涉入的使用药物青年及年轻成年人的前瞻性队列。
  • 使用多变量逻辑回归分析2021年6月至11月期间与SARS-CoV-2疫苗 uptake 相关的因素。
  • 同时收集了疫苗犹豫数据。
  • 研究纳入301名参与者,中位年龄29岁(最小值和最大值:20-40)。

主要发现

  • 301名参与者中,151名(50.2%)自报至少接种一剂SARS-CoV-2疫苗。
  • 多变量分析中,疫苗 uptake 与近期参与成瘾治疗显著相关(AOR=2.46,95%CI:1.47-4.14)。
  • 疫苗 uptake 与获得处方更安全供应(如阿片类药物、兴奋剂)显著相关(AOR=2.33,95%CI:1.03-5.62)。
  • 至少每周使用快克可卡因者接种可能性显著更低(AOR=0.35,95%CI:0.12-0.92)。
  • 疫苗犹豫最常见原因为安全担忧,特别是关于长期副作用(27.4%)。

临床怎么用

  • 研究结果提示将使用药物青年及年轻成年人连接至医疗保健和创新减害干预可能增加疫苗 uptake。
  • 作者建议更广泛策略应对错误信息并促进循证疫苗信息,可量身定制以应对使用药物青年及年轻成年人经历的独特需求和障碍。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: SARS-CoV-2 vaccines provide significant protection against severe illness and death from COVID-19, in addition to reducing community transmission. Emerging research has identified factors associated with vaccine uptake among adults who use drugs; however, less is known about youth and young adults who use drugs (YWUD). To address this gap, we sought to characterize factors associated with vaccine uptake and explore vaccine hesitancy among YWUD. METHODS: Data were derived from the At-Risk Youth Study, a prospective cohort of street-involved YWUD in Vancouver, Canada. Using multivariable logistic regression, we characterized factors associated with SARS-CoV-2 vaccine uptake between June and November 2021. Data on vaccine hesitancy were also collected. RESULTS: Among 301 participants enrolled in this study (median age: 29 [min and max: 20-40]), 151 (50.2%) self-reported receipt of at least one dose of a SARS-CoV-2 vaccine. In multivariable analysis, vaccine uptake was significantly associated with recent addiction treatment engagement (adjusted odds ratio [AOR] = 2.46, 95% confidence interval [CI]: 1.47-4.14) and receiving prescribed safer supply (e.g., opioids, stimulants) (AOR = 2.33, 95% CI: 1.03-5.62). Those who reported at least weekly crack use were significantly less likely to be vaccinated (AOR = 0.35, 95% CI: 0.12-0.92). The most reported reason for vaccine hesitancy was safety concerns, specifically regarding long-term side effects (27.4%). CONCLUSION: Vaccine uptake was significantly lower among YWUD than adults who use drugs in Vancouver and the general population in British Columbia, among whom 75% and 93% received at least one dose during the same period. Study findings suggest connecting YWUD to healthcare and novel harm reduction interventions may increase vaccine uptake. Responses to vaccine hesitancy questions revealed complex perspectives of vaccines that were aligned with sources of vaccine hesitancy among the general population. Broader strategies combatting misinformation and promoting evidence-based vaccine information could be tailored to address the unique needs and barriers experienced by YWUD.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. McAdam E, Hayashi K, Barker B, et al. COVID-19 vaccination among young people who use drugs in Vancouver, Canada. Vaccine. 2024. PMID: 38225183. doi:10.1016/j.vaccine.2024.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。